Cargando…

Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor

INTRODUCTION: Intravitreal dexamethasone and anti-vascular endothelial growth factor (anti-VEGF) medications have revolutionized ocular disease management and favorable ocular safety profiles, but few studies have compared their systemic adverse events (SAEs). This study investigated the SAEs of int...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Tzu-Yi, Hsieh, Yi-Ting, Garg, Sunir J., Chen, Lee-Jen, Chen, Kuan-Jen, Wu, Wei-Chi, Lai, Chi-Chun, Hwang, Yih-Shiou, Kang, Eugene Yu-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011242/
https://www.ncbi.nlm.nih.gov/pubmed/36729247
http://dx.doi.org/10.1007/s40123-023-00659-3